Home › NDC Lookup › RxCUI directory › RxCUI 607579

Entecavir 0.05 MG/ML Oral Solution [Baraclude] — RxCUI 607579

RxNorm drug concept · Semantic branded drug
RxCUI 607579 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI607579
Official nameEntecavir 0.05 MG/ML Oral Solution [Baraclude]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asBaraclude 0.05 MG/ML Oral Solution; Baraclude 0.05 MG in 1 mL Oral Solution; Baraclude 0.05 MG per 1 ML Oral Solution
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)200 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Entecavir: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Entecavir keeps the hepatitis B virus under control by stopping it from copying itself, which protects your liver from ongoing damage. It's not a cure — it doesn't permanently clea...
  • What exactly is entecavir treating — is it curing my hepatitis B?
  • Yes, timing really does matter here. You need to take entecavir on an empty stomach — at least 2 hours after eating and at least 2 hours before your next meal. Studies showed that...
  • Does it matter when I take it — can I take it with breakfast?
📖 Read our full Entecavir guide →

🕸️ Concept Web — How Entecavir 0.05 MG/ML Oral Solution [Baraclude] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Entecavir 0.05 MG/ML Oral Solution [Baraclude] RxCUI 607579

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Entecavir 306266
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Baraclude 588846
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Entecavir Oral Solution 485535
    • Entecavir Oral Liquid Product 1161899
    • Entecavir Oral Product 1161900
    • Entecavir Oral Solution [Baraclude] 607578
    • Baraclude Oral Liquid Product 1168603
    • Baraclude Oral Product 1168604
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Entecavir 0.05 MG/ML Oral Solution SCD · 485536
  • Entecavir 0.05 MG/ML SCDC · 485534
  • Entecavir Oral Solution SCDF · 485535
  • Entecavir Oral Liquid Product SCDG · 1161899
  • Entecavir Oral Product SCDG · 1161900

Brand-Name Concepts

  • Entecavir 0.05 MG/ML [Baraclude] SBDC · 607577
  • Entecavir Oral Solution [Baraclude] SBDF · 607578
  • Baraclude Oral Liquid Product SBDG · 1168603
  • Baraclude Oral Product SBDG · 1168604
  • Baraclude BN · 588846

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 607579 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00003-1611-12 1 BOTTLE in 1 CARTON (0003-1611-12) / 30 TABLET, FILM COATE... BARACLUDE E.R. Squibb & Sons, L.L.C. 2005-03-29
00003-1612-12 1 BOTTLE in 1 CARTON (0003-1612-12) / 30 TABLET, FILM COATE... BARACLUDE E.R. Squibb & Sons, L.L.C. 2005-03-29
00003-1614-12 1 BOTTLE in 1 CARTON (0003-1614-12) / 210 mL in 1 BOTTLE BARACLUDE E.R. Squibb & Sons, L.L.C. 2005-03-29
Observed labelers: E.R. Squibb & Sons, L.L.C. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.